Ocular microdialysis: A continuous sampling technique to study pharmacokinetics and pharmacodynamics in the eye

Bioanalysis

Volumn 2, Issue 3, 2010, Pages 487-507

  Boddu, Sai H S ^a   Gunda, Sriram ^a   Earla, Ravinder ^a   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CEFALEXIN; CEPHALOSPORIN; CORTICOSTEROID; ERYTHROMYCIN; GANCICLOVIR; GENTAMICIN; KETAMINE; NORFLOXACIN; OFLOXACIN; PROPRANOLOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; XYLAZINE;

ANTERIOR EYE CHAMBER; AREA UNDER THE CURVE; BLOOD EYE BARRIER; CONCENTRATION (PARAMETERS); DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; HUMAN; IONIC STRENGTH; MATHEMATICAL COMPUTING; MEMBRANE PERMEABILITY; MICRODIALYSIS; MOLECULAR PROBE; NONHUMAN; OCULAR MICRODIALYSIS; PHARMACODYNAMICS; PHYSICAL CHEMISTRY; PROCESS DESIGN; PROCESS DEVELOPMENT; REVIEW; SKIN INFECTION; TEMPERATURE SENSITIVITY; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT DURATION; VALIDATION PROCESS; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; DRUG EFFECT; EYE; METABOLISM; METHODOLOGY; PHARMACOKINETICS; REPRODUCIBILITY;

ANIMALS; EYE; HUMANS; MICRODIALYSIS; MODELS, BIOLOGICAL; PHARMACOKINETICS; REPRODUCIBILITY OF RESULTS;

EID: 79952469988     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.2     Document Type: Review

References (136)

1. Lee VH, Robinson JR. Topical ocular drug delivery: recent developments and future challenges. J. Ocul. Pharmacol. 2(1), 67-108 (1986). (Pubitemid 17193813)
2. Schoenwald RD. Ocular Pharmacokinetics/ pharmacodynamics. Mitra AK (Ed.). Dekker, NY, USA, 307-330 (1993).
3. Hughes PM, Olejnik O, Chang-Lin JE, Wilson CG. Topical and systemic drug delivery to the posterior segments. Adv. Drug Deliv. Rev. 57(14), 2010-2032 (2005). (Pubitemid 41740793)
4. Kaur IP, Kanwar M. Ocular preparations: the formulation approach. Drug Dev. Ind. Pharm. 28(5), 473-493 (2002). (Pubitemid 34680549)
5. Dias CS, Mitra AK. Posterior segment ocular pharmacokinetics using microdialysis in a conscious rabbit model. Invest. Ophthalmol. Vis. Sci. 44(1), 300-305 (2003). (Pubitemid 36134288)
6. Chefer VI, Thompson AC, Zapata A, Shippenberg TS. Overview of brain microdialysis. Curr. Protoc. Neurosci. 7, 71 (2009).
7. Shippenberg TS, Thompson AC. Overview of microdialysis. Curr. Protoc. Neurosci. 7(7), 1 (2001).
8. Plock N, Kloft C. Microdialysis - theoretical background and recent implementation in applied life-sciences. Eur. J. Pharm. Sci. 25(1), 1-24, (2005). (Pubitemid 40602191)
9. Ungerstedt U, Pycock C. Functional correlates of dopamine neurotransmission. Bull. Schweiz. Akad. Med. Wiss. 30(1-3), 44-55 (1974).
10. Rittenhouse KD, Pollack GM. Microdialysis and drug delivery to the eye. Adv. Drug Deliv. Rev. 45(2-3), 229-241 (2000).
11. Waga J, Ehinger B. Intravitreal concentrations of some drugs administered with microdialysis. Acta Ophthalmol. Scand. 75(1), 36-40 (1997). (Pubitemid 27117181)
12. Gunnarson G, Jakobsson AK, Hamberger A, Sjostrand J. Free amino acids in the pre-retinal vitreous space. Effect of high potassium and nipecotic acid. Exp. Eye Res. 44(2), 235-244 (1987). (Pubitemid 17060569)
13. Ben-Nun J, Cooper RL, Cringle SJ, Constable IJ. Ocular dialysis. A new technique for in vivo intraocular pharmacokinetic measurements. Arch. Ophthalmol. 106(2), 254-259 (1988). (Pubitemid 18056428)
14. Mitra AK. In: Ophthalmic Drug Delivery Systems. Mitra AK (Ed.). Dekker, NY, USA (1993).
15. Verbeeck RK. Blood microdialysis in pharmacokinetic and drug metabolism studies. Adv. Drug Deliv. Rev. 45(2-3), 217-228 (2000).
16. de Lange EC, de Boer AG, Breimer DD. Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv. Drug Deliv. Rev. 45(2-3), 125-148 (2000).
17. Maurice G. Handbook of Experimental Pharmacology. Born VR (Ed.). Springer- Verlag, Berlin, NY, 20-116 (1984).
18. Duvvuri S, Rittenhouse KD, Mitra AK. Microdialysis assessment of drug delivery systems for vitreoretinal targets. Adv. Drug Deliv. Rev. 57(14), 2080-2091 (2005). (Pubitemid 41740798)
19. Macha S. In: Ophthalmic Drug Delivery Systems. Mitra AK (Ed.). Dekker, NY, USA 251-279 (2003).
20. Rittenhouse KD. Ophthalmic Drug Delivery Systems. Dekker, NY, USA, Mitra AK (Ed.). 223-250 (2003).
21. Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv. Drug Deliv. Rev. 58(11), 1131-1135 (2006).
22. Katragadda S, Gunda S, Hariharan S, Mitra AK. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections. Int. J. Pharm. 359(1-2), 15-24 (2008).
23. Raviola G. The structural basis of the blood-ocular barriers. Exp. Eye Res. 25(Suppl.), 27-63 (1977). (Pubitemid 8205026)
24. Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J. Pharmacokinet. Biopharm. 5(5), 445-479 (1977). (Pubitemid 8224518)
25. Drusano GL, Liu W, Perkins R et al. Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program. Antimicrob. Agents. Chemother. 39(8), 1683-1687 (1995).
26. Miller MH, Madu A, Samathanam G et al. Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits. Antimicrob. Agents. Chemother. 36(1), 32-38 (1992).
27. Perkins RJ, Liu W, Drusano G et al. Pharmacokinetics of ofloxacin in serum and vitreous humor of albino and pigmented rabbits. Antimicrob. Agents. Chemother. 39(7), 1493-1498 (1995).
28. Macha S, Mitra AK. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique. Exp. Eye Res. 72(3), 289-299 (2001). (Pubitemid 32977982)
29. de Lange EC, de Boer BA, Breimer DD. Microdialysis for pharmacokinetic analysis of drug transport to the brain. Adv. Drug Deliv. Rev. 36(2-3), 211-227 (1999). (Pubitemid 29121973)
30. Gunaratna PC, Kissinger PT, Kissinger CB, Gitzen JF. An automated blood sampler for simultaneous sampling of systemic blood and brain microdialysates for drug absorption, distribution, metabolism, and elimination studies. J. Pharmacol. Toxicol. Methods 49(1), 57-64 (2004). (Pubitemid 37506055)
31. Chaurasia CS. In vivo microdialysis sampling: theory and applications. Biomed. Chromatogr. 13(5), 317-332 (1999). (Pubitemid 29381285)
32. Hansen DK, Davies MI, Lunte SM, Lunte CE. Pharmacokinetic and metabolism studies using microdialysis sampling. J. Pharm. Sci. 88(1), 14-27 (1999). (Pubitemid 29037363)
33. Wang X, Stenken JA. Microdialysis sampling membrane performance during in vitro macromolecule collection. Anal. Chem. 78(17), 6026-6034 (2006). (Pubitemid 44360113)
34. Torto N, Bang J, Richardson S et al. Optimal membrane choice for microdialysis sampling of oligosaccharides. J. Chromatogr. A 806(2), 265-278 (1998). (Pubitemid 28255418)
35. Winter CD, Iannotti F, Pringle AK, Trikkas C, Clough GF, Church MK. A microdialysis method for the recovery of IL-1b, IL-6 and nerve growth factor from human brain in vivo. J. Neurosci. Methods 119(1), 45-50 (2002). (Pubitemid 35286740)
36. Kendrick KM, Microdialysis measurement of in vivo neuropeptide release. J. Neurosci. Methods 34(1-3), 35-46 (1990). (Pubitemid 20301320)
37. Zetterstrom T, Sharp T, Collin AK, Ungerstedt U. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148(3), 327-334 (1988).
38. Benveniste H, Huttemeier PC. Microdialysis - theory and application. Prog. Neurobiol. 35(3), 195-215 (1990). (Pubitemid 20270228)
39. Wages SA, Church WH, Justice JB Jr. Sampling considerations for on-line microbore liquid chromatography of brain dialysate. Anal. Chem. 58(8), 1649-1656 (1986). (Pubitemid 16589293)
40. Lehmann A. Effects of microdialysis-perfusion with anisoosmotic media on extracellular amino acids in the rat hippocampus and skeletal muscle. J. Neurochem. 53(2), 525-535 (1989). (Pubitemid 19186089)
41. Benveniste H. Brain microdialysis. J. Neurochem. 52(6), 1667-1679 (1989). (Pubitemid 19140749)
42. Lindefors N, Brodin E, Ungerstedt U. Amphetamine facilitates the in vivo release of neurokinin A in the nucleus accumbens of the rat. Eur. J. Pharmacol. 160(3), 417-420 (1989). (Pubitemid 19058187)
43. Alexander GM, Grothusen JR, Schwartzman JR. Flow dependent changes in the effective surface area of microdialysis probes. Life Sci. 43(7), 595-601 (1988).
44. Nicholson C, Rice ME. The migration of substances in the neuronal microenvironment. Ann. NY Acad. Sci. 481, 55-71 (1986). (Pubitemid 17023263)
45. Amberg G, Lindefors N. Intracerebral microdialysis: II. Mathematical studies of diffusion kinetics. J. Pharmacol. Methods 22(3), 157-183 (1989). (Pubitemid 19275443)
46. Rice ME, Gerhardt GA, Hierl PM, Nagy G, Adams RN. Diffusion coefficients of neurotransmitters and their metabolites in brain extracellular fluid space. Neuroscience 15(3), 891-902, (1985). (Pubitemid 15236359)
47. Chastain JE. In: Ophthalmic Drug Delivery Systems. Mitra AK (Ed.). Dekker, NY, USA, 59 (2003).
48. Hart WM. Adler's Physiology of the Eye: Clinical Application. Hart WM, Adler FH (Eds). Mosby Year Book, MO, USA, 248-267 (1992).
49. Davson H. The Physiology of the Eye. Academic Press, NY, USA (1972).
50. Reddy DV, Kinsey VE. Composition of the vitreous humor in relation to that of plasma and aqueous humors. Arch Ophthalmol. 63. 715-720 (1960).
51. Burstein NL, Ophthalmic drug formulations. In: Clinical Ocular Pharmacology (3rd Edition) Bartlet JD, Jaanus SD (Eds). Butterworth- Heinemann, MA, USA, 2, 21-45 (1995).
52. Kendrick KM. Use of microdialysis in neuroendocrinology. Methods Enzymol. 168, 182-205 (1989). (Pubitemid 19136080)
53. Thompson AC, Justice JB Jr, McDonald JK. Quantitative microdialysis of neuropeptide Y. J. Neurosci. Methods 60(1-2), 189-198 (1995).
54. Waga J, Ehinger B. Passage of drugs through different intraocular microdialysis membranes. Graefes Arch. Clin. Exp. Ophthalmol. 233(1), 31-37 (1995).
55. Van Wylen DG, Park TS, Rubio R, Berne RM. Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia. J. Cereb. Blood Flow Metab. 6(5), 522-528 (1986). (Pubitemid 17198735)
56. Delgado JM, Lerma J, Martin del Rio R, Solis JM. Dialytrode technology and local profiles of amino acids in the awake cat brain. J. Neurochem. 42(5), 1218-1228 (1984). (Pubitemid 14137600)
57. Anand BS, Atluri H, Mitra AK. Validation of an ocular microdialysis technique in rabbits with permanently implanted vitreous probes: systemic and intravitreal pharmacokinetics of fluorescein. Int. J. Pharm. 281(1-2), 79-88, (2004). (Pubitemid 39024265)
58. Waga J, Ohta A, Ehinger B. Intraocular microdialysis with permanently implanted probes in rabbit. Acta Ophthalmol. (Copenh.) 69(5), 618-624, (1991).
59. Dey S, Gunda S, Mitra AK. Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption. J. Pharmacol. Exp. Ther. 311(1), 246-255 (2004). (Pubitemid 39287804)
60. Maurice DM. Structures and fluids involved in the penetration of topically applied drugs. Int. Ophthalmol. Clin. 20(3), 7-20 (1980).
61. Doane MG, Jensen AD, Dohlman CH. Penetration routes of topically applied eye medications. Am. J. Ophthalmol. 85(3), 383-386 (1978). (Pubitemid 8313843)
62. Maurice DM. Factors influencing the penetration of topically applied drugs. Int. Ophthalmol. Clin. 20(3), 21-32 (1980).
63. Levine JM, Noecker RJ, Lane LC, Herrygers L, Nix D, Snyder RW. Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. J. Cataract Refract. Surg. 30(10), 2177-2182 (2004). (Pubitemid 39330678)
64. Chien DS, Schoenwald RD. Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes. Pharm. Res. 7(5), 476-483 (1990). (Pubitemid 20322197)
65. Schoenwald RD. Ophthalmic Drug Delivery Systems. Mitra AK (Ed.). Dekker, NY, USA 135-180 (2003).
66. Lee VH, Robinson JR. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J. Pharm. Sci. 68(6), 673-684 (1979). (Pubitemid 9214368)
67. Makoid MC, Robinson JR. Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye. J. Pharm. Sci. 68(4), 435-443 (1979). (Pubitemid 9167458)
68. Sieg JW, Robinson JR. Vehicle effects on ocular drug bioavailability II: evaluation of pilocarpine. J. Pharm. Sci. 66(9), 1222-1228 (1977). (Pubitemid 8163965)
69. Eller MG, Schoenwald RD, Dixson JA, Segarra T, Barfknecht CF. Topical carbonic anhydrase inhibitors IV: relationship between excised corneal permeability and pharmacokinetic factors. J. Pharm. Sci. 74(5), 525-529 (1985). (Pubitemid 15064590)
70. Hughes PM, Mitra AK. Effect of acylation on the ocular disposition of acyclovir. II: corneal permeability and anti-HSV 1 activity of 2′-esters in rabbit epithelial keratitis. J. Ocul. Pharmacol. 9(4), 299-309 (1993). (Pubitemid 24006862)
71. Tirucherai GS, Dias C, Mitra AK. Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design. J. Ocul. Pharmacol. Ther. 18(6), 535-548 (2002). (Pubitemid 36020255)
72. Gunda S, Hariharan S, Mitra AK. Corneal absorption and anterior chamber pharmacokinetics of dipeptide monoester prodrugs of ganciclovir (GCV): in vivo comparative evaluation of these prodrugs with Val-GCV and GCV in rabbits. J. Ocul. Pharmacol. Ther. 22(6), 465-476 (2006). (Pubitemid 46110643)
73. Hariharan S, Gunda S, Mishra GP, Pal D, Mitra AK. Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroids. Pharm. Res. 26(5), 1270-1282 (2009).
74. Lopez-Cortes LF, Pastor-Ramos MT, Ruiz-Valderas R et al. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits. Invest. Ophthalmol. Vis. Sci. 42(5), 1024-1028 (2001). (Pubitemid 32289799)
75. Fukuda M, Mikitani M, Ueda T et al. Application of microdialysis on analysis of pharmacokinetics in domestic rabbits aqueous humor. Jpn. Ophthalmol. Soc. 99, 400-405 (1995).
76. Sato H, Fukuda S, Inatomi M et al. Pharmacokinetics of norfloxacin and lomefloxacin in domestic rabbit aqueous humor analyzed by microdialysis. Jpn. Ophthalmol. Soc. 100, 513-519 (1996). (Pubitemid 26286483)
77. Ohtori R, Sato H, Fukuda S et al. Pharmacokinetics of topical b-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method. Exp. Eye Res. 66(4), 487-494 (1998). (Pubitemid 28206781)
78. Rittenhouse KD, Peiffer RL Jr, Pollack GM. Evaluation of microdialysis sampling of aqueous humor for in vivo models of ocular absorption and disposition. J. Pharm. Biomed. Anal. 16(6), 951-959 (1998). (Pubitemid 28139032)
79. Rittenhouse KD, Peiffer RL Jr, Pollack GM. Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit. Pharm. Res. 16(5), 736-742 (1999). (Pubitemid 29227105)
80. Rittenhouse KD, Peiffer RL Jr, Pollack GM. Assessment of ascorbate ocular disposition in the conscious rabbit: an approach using the microdialysis technique. Curr. Eye Res. 20(5), 351-360 (2000). (Pubitemid 30614571)
81. Rittenhouse KD, Pollack GM. Pharmacodynamics of b-blocker modulation of aqueous humor production. Exp. Eye Res. 70(4), 429-439 (2000). (Pubitemid 30658886)
82. Palestine AG, Polis MA, De Smet MD et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann. Intern. Med. 115(9), 665-673 (1991).
83. Pavan PR, Oteiza EE, Hughes BA, Avni A. Exogenous endophthalmitis initially treated without systemic antibiotics. Ophthalmology 101(7), 1289-1296; discussion 1296-1287 (1994).
84. Daily MJ, Peyman GA, Fishman G. Intravitreal injection of methicillin for treatment of endophthalmitis. Am. J. Ophthalmol. 76(3), 343-350 (1973).
85. Stempels N, Tassignon MJ, Sarre S. A removable ocular microdialysis system for measuring vitreous biogenic amines. Graefes Arch. Clin. Exp. Ophthalmol. 231(11), 651-655 (1993). (Pubitemid 23342238)
86. Hughes PM, Krishnamoorthy R, Mitra AK. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique. J. Ocul. Pharmacol. Ther. 12(2), 209-224 (1996). (Pubitemid 26164534)
87. Chader G, Sears ML. Pharmacology of the Eye. Springer-Verlag, Berlin, Germany (1984).
88. Atluri H, Mitra AK. Disposition of short-chain aliphatic alcohols in rabbit vitreous by ocular microdialysis. Exp. Eye Res. 76(3), 315-320 (2003). (Pubitemid 36263330)
89. Macha S, Duvvuri S, Mitra AK. Ocular disposition of novel lipophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis. Curr. Eye Res. 28(2), 77-84 (2004). (Pubitemid 38200942)
90. Macha S, Mitra AK. Ocular pharmacokinetics of cephalosporins using microdialysis. J. Ocul. Pharmacol. Ther. 17(5), 485-498 (2001). (Pubitemid 33116125)
91. Duvvuri S, Gandhi MD, Mitra AK. Effect of P-glycoprotein on the ocular disposition of a model substrate, quinidine. Curr. Eye Res. 27(6), 345-353 (2003). (Pubitemid 38019201)
92. Dias C, Nashed Y, Atluri H, Mitra A. Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: an evaluation using ocular microdialysis and LC-MS. Curr. Eye Res. 25(4), 243-252 (2002). (Pubitemid 36307990)
93. Duvvuri S, Janoria KG, Pal D, Mitra AK. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,l-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. J. Ocul. Pharmacol. Ther. 23(3), 264-274 (2007). (Pubitemid 46986607)
94. Peng GW, Chiou WL. Analysis of drugs and other toxic substances in biological samples for pharmacokinetic studies. J. Chromatogr. 531, 3-50 (1990). (Pubitemid 20324565)
95. Fu J, Feng X, Yuan H et al. Study of ocular pharmacokinetics of in situ gel system for S(-)-satropane evaluated by microdialysis. J. Pharm. Biomed. Anal. 48(3), 840-843 (2008).
96. Davies MI, Cooper JD, Desmond SS, Lunte CE, Lunte SM. Analytical considerations for microdialysis sampling. Adv. Drug Deliv. Rev. 45(2-3), 169-188 (2000).
97. Riley CM, Ault JM, Lunte CE. In: Progress in Pharmaceutical and Biomedical Analysis. Riley C, Lough W, Wainer I (Eds). Pergamon, NY, USA, 193-239 (1994).
98. Bergstrom SK, Markides KE. On-line coupling of microdialysis to packed capillary column liquid chromatography-tandem mass spectrometry demonstrated by measurement of free concentrations of ropivacaine and metabolite from spiked plasma samples. J. Chromatogr. 775(1), 79-87 (2002). (Pubitemid 34717924)
99. Niwa O, Torimitsu K, Morita M, Osborne P, Yamamoto K. Concentration of extracellular l-glutamate released from cultured nerve cells measured with a small-volume online sensor. Anal. Chem. 68(11), 1865-1870 (1996).
100. Wagstaff JD, Gibb JW, Hanson GR. Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis. Brain Res. 721(1-2), 196-203 (1996).
101. Boismenu D, Mamer O, Ste-Marie L, Vachon L, Montgomery J. In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors: electrospray-MS analysis of intra-striatal microdialysates. J. Mass Spectrom. 31(10), 1101-1108 (1996). (Pubitemid 26360244)
102. Macha S, Mitra AK. Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis. Drug Metab. Dispos. 30(6), 670-675 (2002). (Pubitemid 34579101)
103. Hogan BL, Lunte SM, Stobaugh JF, Lunte CE. On-line coupling of in vivo microdialysis sampling with capillary electrophoresis. Anal. Chem. 66(5), 596-602 (1994).
104. Zhou SY, Zuo H, Stobaugh JF, Lunte CE, Lunte SM. Continuous in vivo monitoring of amino acid neurotransmitters by microdialysis sampling with on-line derivatization and capillary electrophoresis separation. Anal. Chem. 67(3), 594-599 (1995).
105. Janoria KG, Boddu SH, Wang Z et al. Vitreal pharmacokinetics of biotinylated ganciclovir: role of sodium-dependent multivitamin transporter expressed on retina. J. Ocul. Pharmacol. Ther. 25(1), 39-49 (2009).
106. Majumdar S, Kansara V, Mitra AK. Vitreal pharmacokinetics of dipeptide monoester prodrugs of ganciclovir. J. Ocul. Pharmacol. Ther. 22(4), 231-241 (2006). (Pubitemid 44689662)
107. Hicks JM. Fluorescence immunoassay. Hum. Pathol. 15(2), 112-116 (1984). (Pubitemid 14194125)
108. Waga J, Ehinger B. NGF administered by microdialysis into rabbit vitreous. Acta Ophthalmol. Scand. 78(2), 154-155 (2000). (Pubitemid 30201421)
109. Li X, Nie SF, Kong J, Li N, Ju CY, Pan WS. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int. J. Pharm. 363(1-2), 177-182 (2008).
110. Prokai L, Kim HS, Zharikova A et al. Electrospray ionization mass spectrometric and liquid chromatographic-mass spectrometric studies on the metabolism of synthetic dynorphin A peptides in brain tissue in vitro and in vivo. J. Chromatogr. A 800(1), 59-68 (1998). (Pubitemid 28154864)
111. Huynh BH, Fogarty BA, Martin RS, Lunte SM. On-line coupling of microdialysis sampling with microchip-based capillary electrophoresis. Anal. Chem. 76(21), 6440-6447 (2004). (Pubitemid 39458480)
112. Ben-Nun J, Cooper RL, Cringle SJ, Constable IJ. A new method for continuous intraocular drug delivery. Aust. N. Z. J. Ophthalmol. 17(2), 185-190 (1989). (Pubitemid 19190842)
113. Ben-Nun J, Joyce DA, Cooper RL, Cringle SJ, Constable IJ. Pharmacokinetics of intravitreal injection. Assessment of a gentamicin model by ocular dialysis. Invest. Ophthalmol. Vis. Sci. 30(6), 1055-1061 (1989). (Pubitemid 19164921)
114. Louzada-Junior P, Dias JJ, Santos WF, Lachat JJ, Bradford HF, Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina: an approach using microdialysis. J. Neurochem. 59(1), 358-363 (1992).
115. Tsai G, Stauch BL, Vornov JJ, Deshpande JK, Coyle JT. Selective release of N-acetylaspartylglutamate from rat optic nerve terminals in vivo. Brain Res. 518(1-2), 313-316 (1990). (Pubitemid 20197066)
116. Stempels N, Tassignon JM, Sarre S, Nguyen-Legros J. Microdialysis measurement of catecholamines in rabbit vitreous after retinal laser photocoagulation. Exp. Eye Res. 59(4), 433-439 (1994). (Pubitemid 24352077)
117. Tassignon JM. Principles of the use of thermal laser photocoagulation in diabetic retinopathy. Bull. Soc. Belge. Ophtalmol. 256, 73-79 (1995).
118. Yamanaka T, Sasa M, Matsunaga T. Release of glutamate from the vestibular nerve in the medial vestibular nucleus as a neurotransmitter: in vivo microdialysis study. Acta Otolaryngol. 520 (Suppl., Pt 1), 92-93 (1995).
119. Adachi A, Hasegawa M, Ebihara S. Measurement of circadian rhythms of ocular melatonin in the pigeon by in vivo microdialysis. Neuroreport 7(1), 286-288 (1995). (Pubitemid 26077244)
120. Ebihara S, Adachi A, Hasegawa M, Nogi T, Yoshimura T, Hirunagi K. In vivo microdialysis studies of pineal and ocular melatonin rhythms in birds. Biol. Signals 6(4-6), 233-240 (1997). (Pubitemid 28052573)
121. McElligott JG, Beeton P, Polk J. Effect of cerebellar inactivation by lidocaine microdialysis on the vestibuloocular reflex in goldfish. J. Neurophysiol. 79(3), 1286-1294 (1998). (Pubitemid 28125364)
122. Adachi A, Nogi T, Ebihara S. Phase-relationship and mutual effects between circadian rhythms of ocular melatonin and dopamine in the pigeon. Brain Res . 792(2), 361-369 (1998). (Pubitemid 28267556)
123. Kurata N. [Peripheral tissue microdialysis technique in unrestrained, conscious animals]. Nippon Yakurigaku Zasshi 116(3), 181-187 (2000).
124. Waga J, Nilsson-Ehle I, Ljungberg B, Skarin A, Stahle L, Ehinger B. Microdialysis for pharmacokinetic studies of ceftazidime in rabbit vitreous. J. Ocul. Pharmacol. Ther. 15(5), 455-463 (1999). (Pubitemid 29480963)
125. Waga J. Ganciclovir delivery through an intravitreal microdialysis probe in rabbit. Acta Ophthalmol. Scand. 78(3), 369-371 (2000). (Pubitemid 30333317)
126. Zhang XM, Ohishi K, Hiramitsu T. Microdialysis measurement of ascorbic acid in rabbit vitreous after photodynamic reaction. Exp. Eye Res. 73(3), 303-309 (2001). (Pubitemid 32977196)
127. Palhalmi J, Szikra T, Kekesi KA, Papp A, Juhasz G. An in vivo eyecup preparation for the rat. J. Neurosci. Methods 105(2), 167-174 (2001). (Pubitemid 32223937)
128. Wei G, Ding PT, Zheng JM, Lu WY. Pharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels. Biomed. Chromatogr. 20(1), 67-71 (2006). (Pubitemid 43148625)
129. Okuno T, Oku H, Sugiyama T, Ikeda T. Glutamate level in optic nerve head is increased by artificial elevation of intraocular pressure in rabbits. Exp. Eye Res. 82(3), 465-470 (2006). (Pubitemid 43138960)
130. Anand BS, Katragadda S, Gunda S, Mitra AK. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits. Mol. Pharm. 3(4), 431-440 (2006).
131. Aggarwal D, Pal D, Mitra AK, Kaur IP. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor. Int. J. Pharm. 338(1-2), 21-26 (2007). (Pubitemid 46777217)
132. Cao Y, Zhang C, Shen W, Cheng Z, Yu LL, Ping Q. Poly(N- isopropylacrylamide)- chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J. Control Release 120(3), 186-194 (2007). (Pubitemid 47058641)
133. Liu Z, Yang XG, Li X, Pan W, Li J. Study on the ocular pharmacokinetics of ion-activated in situ gelling ophthalmic delivery system for gatifloxacin by microdialysis. Drug Dev. Ind. Pharm. 33(12), 1327-1331 (2007).
134. Senthilkumari S, Velpandian T, Biswas NR, Saxena R, Ghose S. Evaluation of the modulation of P-glycoprotein (P-gp) on the intraocular disposition of its substrate in rabbits. Curr. Eye Res. 33(4), 333-343 (2008). (Pubitemid 351507755)
135. Karla PK, Quinn TL, Herndon BL, Thomas P, Pal D, Mitra A. Expression of multidrug resistance associated protein 5 (MRP5) on cornea and its role in drug efflux. J. Ocul. Pharmacol. Ther. 25(2), 121-132 (2009).
136. Liu Z, Zhang X, Li J, Liu R, Shu L, Jin J. Effects of labrasol on the corneal drug delivery of baicalin. Drug Deliv. 16(7), 399-404 (2009).